NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $624,000 | +145.7% | 26,599 | +28.3% | 0.02% | +183.3% |
| Q4 2016 | $254,000 | -40.2% | 20,729 | -16.2% | 0.01% | -40.0% |
| Q3 2016 | $425,000 | +11.5% | 24,723 | -7.5% | 0.01% | +25.0% |
| Q2 2016 | $381,000 | +95.4% | 26,741 | +130.7% | 0.01% | +166.7% |
| Q4 2015 | $195,000 | -18.8% | 11,593 | -39.6% | 0.00% | -25.0% |
| Q2 2015 | $240,000 | +71.4% | 19,207 | +51.3% | 0.00% | +33.3% |
| Q1 2015 | $140,000 | -68.0% | 12,692 | -65.0% | 0.00% | -62.5% |
| Q3 2014 | $437,000 | +30.1% | 36,234 | +38.2% | 0.01% | +60.0% |
| Q2 2014 | $336,000 | +116.8% | 26,214 | +105.4% | 0.01% | +150.0% |
| Q1 2014 | $155,000 | -61.6% | 12,762 | -67.0% | 0.00% | -60.0% |
| Q3 2013 | $404,000 | – | 38,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |